I was a bit harsh, I admit. That being said, the claim of 10x reduction is definitely a misrepresentation of the research findings. The 10x reduction was not fo

I was a bit harsh, I admit. That being said, the claim of 10x reduction is definitely a misrepresentation of the research findings. The 10x reduction was not for people who have had HSV-1 infection at some point in their life, it was for people who were diagnosed with an HSV infection at the beginning of the study. Most people who get cold sores don't seek medical attention for that, they just either ride it out, or apply some Abreva that they buy at their local pharmacy. The population that was subject to the study in no way represents 54% of the total population. And then, the population for which the 10x reduction of dementia risk was only a small subpopulation, namely those where an "aggressive antiviral treatment was applied". The actual article quoted ([1]) even stressed that: "It should be stressed that [...] those treated were the few rare cases severely affected by HSV." [1] https://content.iospress.com/articles/journal-of-alzheimers-disease/jad180266 https://content.iospress.com/articles/journal-of-alzheimers-...